U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 1 of 1 results

NIFURTIMOX

MORE DETAILS

  M84I3K7C2O

Status:
US Approved Rx (2020)
First approved in 2020
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Rhodesain
1
Trypanosoma cruzi
12
Conditions:
Chagas disease
19
Neuroblastoma
26
Medulloblastoma
5
African trypanosomiasis
11
Nifurtimox is a nitrofuran derivative used as a primary agent in the treatment of American trypanosomiasis (Chagas' disease) caused by Trypanosoma cruzi, especially in the acute, early stage of the disease. The efficacy of nifurtimox in the treatment...
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966